Houston Methodist, which Mary Bowden sued for defamation after it suspended her admitting privileges, "collects up to ...

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Halozyme ...

Novavax’s CEO reviewed the company’s successes in 2025 and shared its growth strategy for 2026 and beyond at a recent ...

Novavax entered the 2026 J.P. Morgan Healthcare Conference positioning itself as a partner-driven company focused on ...

At the 44th Annual J.P. Morgan Healthcare Conference on 14 January 2026, Novavax outlined a new partner-led business model, ...

Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

Buying vaccine biotech Dynavax was an easy choice for Sanofi despite antivaccine moves by the Trump administration.

CDC Spokesperson Lin Ming-cheng (林明誠) said signs of a rebound in flu activity are evident, with the epidemic phase expected to begin in two weeks and peak around the Lunar New Year. However, the peak ...

Novavax Inc (NASDAQ:NVAX) shares are trading higher. Reports show a rise in respiratory illnesses across the United States.

Shares rose 6.6% Monday on new partnership strategy outlined at J.P. Morgan conference. Sanofi deal and cost cuts drive ...

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Novavax faces significant financial challenges, with high leverage and declining revenue growth. While strategic partnerships and asset restructuring provide some optimism, the overall outlook remains ...